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Abstract
Introduction: Offspring of Schistosoma mansoni-infected women in schistosomiasis-endemic areas may be sensitised in-
utero. This may influence their immune responsiveness to schistosome infection and schistosomiasis-associated morbidity.
Effects of praziquantel treatment of S. mansoni during pregnancy on risk of S. mansoni infection among offspring, and on
their immune responsiveness when they become exposed to S. mansoni, are unknown. Here we examined effects of
praziquantel treatment of S. mansoni during pregnancy on prevalence of S. mansoni and immune responsiveness among
offspring at age five years.
Methods: In a trial in Uganda (ISRCTN32849447, http://www.controlled-trials.com/ISRCTN32849447/elliott), offspring of
women treated with praziquantel or placebo during pregnancy were examined for S. mansoni infection and for cytokine
and antibody responses to SWA and SEA, as well as for T cell expression of FoxP3, at age five years.
Results: Of the 1343 children examined, 32 (2.4%) had S. mansoni infection at age five years based on a single stool sample.
Infection prevalence did not differ between children of treated or untreated mothers. Cytokine (IFNc, IL-5, IL-10 and IL-13)
and antibody (IgG1, Ig4 and IgE) responses to SWA and SEA, and FoxP3 expression, were higher among infected than
uninfected children. Praziquantel treatment of S. mansoni during pregnancy had no effect on immune responses, with the
exception of IL-10 responses to SWA, which was higher in offspring of women that received praziquantel during pregnancy
than those who did not.
Conclusion: We found no evidence that maternal S. mansoni infection and its treatment during pregnancy influence
prevalence and intensity of S. mansoni infection or effector immune response to S. mansoni infection among offspring at
age five years, but the observed effects on IL-10 responses to SWA suggest that maternal S. mansoni and its treatment
during pregnancy may affect immunoregulatory responsiveness in childhood schistosomiasis. This might have implications
for pathogenesis of the disease.
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Introduction
In-utero sensitisation to schistosome antigens occurs in up to 50%
of offspring born to women with schistosomiasis during
pregnancy [1,2]. Those who do not show an immune response
may not have been exposed to relevant antigen (due to the
placental barrier) or may have been exposed and developed
tolerance. For those who are tolerant, this may be due to
induction of regulatory mechanisms, or to deletion of schistosome
antigen specific cells. When the baby is sensitised in-utero, profiles
of infant responses resemble the mothers’ responses: mixed type
one, type two cytokine responses and a prominent IL-10
response, as shown by our recent study on cord blood responses
to schistosome worm (SWA) and egg (SEA) [3] and one earlier
study [2]. Our study suggested a direct correlation between
maternal S. mansoni infection intensity and cord blood T cell
sensitisation of the offspring [3]. Thus immune responses to
schistosome antigens typical of those observed in adults can be
established in-utero in offspring born to schistosome-infected
women.
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In communities where schistosomiasis is endemic, an age-
dependent build up of immune response and resistance to S.
mansoni infection has been described [4,5]. There is a possibility
that, in addition to this, immune responses established in-utero
might influence early childhood responses and resistance to
infection. On the other hand, children who are exposed in-utero,
but do not become sensitised, may have acquired tolerance to
schistosome antigens, which might render them more susceptible
to infection, as has been observed among offspring of women with
filariasis [6]. In-utero sensitisation to schistosome antigens might
also influence schistosomiasis morbidity. For example, the low
incidence of the acute schistosomiasis syndrome, Katayama fever
[7], in endemic populations is attributed to early or in-utero
sensitisation such that they are able to modulate the immune
response and subsequent pathology associated with S. mansoni
infection.
Balanced type one/type two immune responses are needed to
limit morbidity [8,9,10,11,12], and responses established in-utero
could influence this balance. Studies in mice support the
hypothesis that in-utero anti-idiotypic exposure induces B and T
cell responsiveness to schistosome antigens recognised by the
idiotype [13], and that this exposure induces immmunoregulatory
effects in subsequent schistosomiasis infection [14]. Recent
immunoepidemiological studies in Kenya involving school age
children (4–17 years) in S. mansoni endemic areas showed that
regulatory cytokines are important in schistosomiasis morbidity
[15], and that dysregulation of pro-inflammatory cytokines could
be a mechanism involved in childhood hepatosplenomegaly
observed in schistosomiasis.
It is estimated that in Africa up to 10 million women per year
have schistosomiasis during pregnancy [16], and 40 million
women of child-bearing age have schistosomiasis [17]. Here we
report results on follow-up of offspring at five years old, exploring
the hypothesis that schistosomiasis and its treatment during
pregnancy could influence the immune responses of the children
when they themselves are exposed to S. mansoni infection. Based on
the immunoepidemiological studies that explored association of
the various cytokines with S mansoni morbidity [15,18,19], we
measured IFN, IL-5, IL-13 and IL-10 responses to schistosome
worm (SWA) and egg (SEA) antigens and regulatory T-cells.
Methods
Ethics statement
Written informed consent was obtained from each participant
[20]. For all the children’s participation, written informed consent
was obtained from their parent or guardian. Ethical approval was
obtained from the Science and Ethics Committees of the Uganda
Virus Research Institute – Ministry of Health, the Uganda
National Council for Science and Technology and the London
School of Hygiene and Tropical Medicine.
Study setting, subjects and sample collection
This study was a follow-up of children within the ‘Entebbe
Mother and Baby Study’ (EMaBS; ISRCTN 32849447) [20].
EMaBS was a randomised, double-blind placebo-controlled trial
of praziquantel versus matching placebo and albendazole versus
matching placebo during pregnancy using a 262 factorial design.
It was conducted within Entebbe municipality and the adjacent
Katabi sub-county in Uganda. Previous policy had excluded
pregnant and lactating women from the control of schistosomiasis
using praziquantel treatment [21], and although this policy was
rescinded [22] there had been limited information on the effects of
praziquantel treatment of schistosomiasis during pregnancy
regarding anticipated benefits (on outcomes such as anaemia
and birth weight) or possible adverse effects on the developing
fetus. Hence there was considered to be the required equipoise to
justify placebo-controlled trials [23]. Pregnant women were
recruited between April 2003 and November 2005. At recruit-
ment, the women provided stool samples that were examined for
intestinal helminths including S. mansoni infection using the Kato
Katz method [24]. Children were followed up annually and stool
and blood samples were collected at each visit. For the current
study, we focussed on offspring of the study women at age five
years.
The stool samples were examined for helminth infections
including S. mansoni by the Kato Katz method for all children.
Blood samples (approximately 6 mL) were processed for immune
responses, plasma was separated and stored at 280uC, and
peripheral blood mononuclear cells (PBMCs) were isolated and
stored in liquid nitrogen. For schistosome immunology studies,
whole blood culture for responses to schistosome antigens, and
anti-schistosome antibody assays, were performed in a subgroup of
436 children, comprising 190 whose mothers had S. mansoni
infection during pregnancy and, for comparison, a consecutive
series of 246 children whose mothers did not.
Whole blood culture and cytokine assay
Whole blood stimulation for cytokine responses to SWA and
SEA was performed as previously described [3,25,26,27]. SWA
and SEA antigens were supplied by Professor David Dunne
(Cambridge University, UK). The levels of endotoxin in the
antigen preparations were 0.086 EU/mg for SWA and
0.175 EU/mg for SEA. On dilution of the antigen to working
concentration of 10 mg/ml, the endotoxin levels in culture were
negligible (,0.1 ng/ml) and unlikely to influence cytokine
responses in whole blood culture. Briefly, heparinised blood was
diluted 1 in 4 with serum-free medium (RPMI supplemented with
glutamine, penicillin and streptomycin) and stimulated with SWA,
SEA or phytohaemagglutinin (PHA- Sigma, UK) at final
concentrations of 10 mg/ml in 96-well round-bottomed cell culture
plates (TC Microwell, NUNC A/S, Roskelde, Denmark), or left
Author Summary
Infections with the blood fluke Schistosoma mansoni that
cause schistosomiasis (also called Bilharzia) were not
usually treated during pregnancy until 2002, but in 2002
a World Health Organization (WHO) team of experts
recommended that praziquantel treatment of S. mansoni
during pregnancy should be done. However, there was
limited information on the effects of maternal S. mansoni
infection and treatment during pregnancy on the out-
comes in the offspring. We conducted a study in the
Entebbe peninsula within Lake Victoria in Uganda to
examine whether maternal S. mansoni infection or its
treatment during pregnancy may have effects on the
children’s susceptibility to the infection. The children were
examined at age five years old for the level of S. mansoni
infection and for immune responses to schistosomes. At
five years old few of the children in our study cohort were
infected with S. mansoni. Our findings suggest that
maternal infection with, or praziquantel treatment of S.
mansoni during pregnancy did not influence the level of S.
mansoni infection among the offspring. However our
findings suggest an influence on regulation of the body’s
immune responses to schistosomes, which may have some
effect on the progress of disease manifestations. This is an
issue that needs further investigation.
Childhood Immune Response to S. mansoni
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unstimulated. Media (200 ml per well) was added to the plates and
incubated at 37uC and 5% CO2. Supernatants were harvested
after six days and left to stand at room temperature for one hour
with viral inactivation buffer (0.03% tributyl phosphate and 1%
Tween 80 (Sigma)) before storage at 280uC until needed for
analysis.
The supernatants were assessed for interferon gamma (IFNc),
interleukin (IL)-5, IL-13 and IL-10 responses to SWA and SEA.
IFNc, IL-5 and IL-10 concentration in the supernatants was
measured using OptEIA ELISA Kits (BD Pharmingen, USA)
while IL-13 was measured using antibody pairs (BD Pharmingen,
USA), with standards from the National Institute for Biological
Standards and Controls (NIBSC, UK). The sensitivity of each
assay, and cut-off for detectable responses, was the lowest
concentration on the standard curve (9 pg/ml for IFNc, 8 pg/
ml for IL-5 and IL-10 and 16 pg/ml for IL-13). Cytokine levels in
unstimulated cultures were generally low (Figure S1). To obtain
antigen-specific responses, cytokine concentrations in unstimulated
wells were subtracted from the measured concentrations in
antigen-stimulated wells.
Assay of antibodies to schistosome antigens
Plasma levels of IgG1, IgG4 and IgE to SWA and SEA were
measured in duplicate by ELISA [24] with a high through-put
semi-automated system. Briefly, flat bottomed 384-well micro-
plates (Greiner Bio-One Ltd, Stonehouse, UK) were coated with
SWA (8 mg/ml) or SEA (2.4 mg/ml) in 25 ml bicarbonate coating
buffer and incubated overnight at 4uC. A standard positive pool
and myeloma immunoglobulin isotype were added to allow a
standard curve for quantification of antibodies to be generated.
Samples were added at 25 ml per well at dilutions of 1/200 for
IgG1 and IgG4 or 1/20 for IgE and incubated overnight at 4uC.
Biotinylated mouse anti-human monoclonal antibodies (BD
Pharmingen San Diego USA) were used for detection and Poly-
HRP-streptavidin conjugate (Sanquin, Netherlands) was added at
a 1/4000 dilution. Plates were developed with OPD substrate and
stopped with 2 M sulphuric acid on observing the colour change.
Optical densities (ODs) were recorded using Gen5 software.
Concentrations were calculated from ODs by interpolation from
standard curves. Normal European serum was included as a
negative control to determine the cut-offs for positive levels. The
cut-offs were set at three standard deviations above the mean of
the normal European sera, which was 0.4 mg/ml for IgG1 to
SWA, 0.1 mg/mL for IgG1 to SEA, 0.544 mg/ml for IgG4 to
SWA, 0.042 mg/mL for IgG4 to SEA, 0.16 mg/mL for IgE to
SWA and 0.04 mg/mL for IgE to SEA.
Flow cytometry analysis of PBMCs for regulatory T Cells
PBMCs were stained for surface CD4, CD25, CD127 and
intracellular FoxP3 to determine regulatory T cell (Treg)
frequencies. Antibodies for surface marker staining were fluor-
escine isothiocyanate (FITC) labelled mouse anti-human CD4
(Invitogen-Caltag, Camarillo, USA) , phycoerythrin (PE) labelled
mouse antihuman CD25 (Invitogen-Caltag, Camarillo, USA) and
mouse anti-human CD127-Alexa647 (BD Pharmingen San Diego
USA). Intracellular FoxP3 was detected using rat anti-human
FoxP3-PE-cy5 (eBioscience, San Diego USA). PBMCs were
thawed, washed and cell numbers determined. Between 1 and 2
million cells were stained in V-bottom 96-well plates. The cells
were stained for 20 minutes in the dark at 4uC in 100 ml surface
mix comprising surface antibodies CD4-FITC, CD25-PE and
CD127-Alexa647 at dilutions 1:40, 1:20 and 1:10 respectively.
The cells were washed, permeabilized and stained for FoxP3
according to eBioscience’s recommended protocol. The cells were
acquired using FACS Diva software on a 17-colour flow cytometer
(LSR II BD Biosciences) within 12 hours of staining. The acquired
data was analysed using FlowJo software. Regulatory T cells
(Tregs) were defined as CD4+ CD127low, CD25+ and FoxP3+.
An example of the gating strategy applied can be viewed in Figure
S2. The frequency of cells expressing FoxP3 was expressed as a
percentage of CD4+ cells and the expression level of FoxP3
expressed in terms of geometric mean fluorescent intensity
(GMFI).
Statistical analysis
The analysis had four main objectives. (1) In the whole cohort,
we examined whether S. mansoni infection during pregnancy was
associated with childhood S. mansoni infection among the offspring
at age five years. This was done using logistic regression to
calculate odds ratios of infection among offspring at age five years,
comparing prevalence among children of women who had S.
mansoni infection during pregnancy with children of those who did
not. For this observational analysis we also adjusted for factors that
had a potential association with maternal S. mansoni infection in
both mother and child, such as maternal residence, contact with
lake water, maternal education, household socioeconomic status,
maternal hookworm and Mansonella infections, using multivariable
logistic regression. (2) In the whole cohort, we examined the effect
of praziquantel treatment of S. mansoni infection during pregnancy
on S. mansoni infection among the offspring at age five years. This
was done by logistic regression comparing children of women that
were treated, with children of women that were not treated. The
possibility of a differential effect of maternal praziquantel
treatment by maternal S. mansoni status was evaluated by
conducting a subgroup analysis and calculating the p-value for
the interaction. Since the prevalence of S. mansoni infection among
children at age five years was very low, we further explored the
consistency of the observed effect for objectives 1 and 2 using data
collected at all annual visits, from age one year to age eight years,
using repeated measures analysis combining available infection
data from all time points. (3) In the subgroup selected for
schistosome immunology studies, we examined associations
between the schistosome-specific immune responses of the
offspring at age five years and maternal S. mansoni infection during
pregnancy, and associations between schistosome-specific immune
responses in five year olds and praziquantel treatment during
pregnancy. This was done by comparing cytokine and antibody
responses to SWA and SEA between offspring of women who had
S. mansoni infection during pregnancy and those that did not
(restricting to the placebo group), and between children of women
of the praziquantel and placebo groups (restricting to infected
women). Cytokine and antibody responses had skewed distribu-
tions. The data were therefore log10 transformed and analysed by
linear regression with bootstrapping to estimate bias-corrected
accelerated regression coefficients and 95% confidence intervals
that were back-transformed to give geometric mean ratios. Levels
were also compared between infected and uninfected children
using Wilcoxon rank sum test. (4) We examined the effect of
maternal schistosomiasis and treatment during pregnancy on
regulatory T cells in the offspring. This was done by comparing
the proportion of CD4+ cells that expressed FoxP3, and the levels
of FoxP3 expression, between children of women with schistoso-
miasis and those without, and also between children of infected
women that were treated or not. Similarly, these comparisons were
done by linear regression with bootstrapping to estimate bias-
corrected accelerated regression coefficients and 95% confidence
intervals that were transformed to give geometric mean ratios.
Childhood Immune Response to S. mansoni
PLOS Neglected Tropical Diseases | www.plosntds.org 3 October 2013 | Volume 7 | Issue 10 | e2501
Results
Baseline characteristics of the study cohort
Of the 2507 women enrolled in the main study, 2345 live births
were recorded and 1343 of these children were examined for S.
mansoni at age five years, 703 in the placebo group and 640 in the
praziquantel group. The baseline characteristics of the mothers as
recorded at enrolment into the study during pregnancy did not
significantly differ between the praziquantel and placebo arms
(Table 1). Among the placebo group (n = 703), 571 (81.2%) were
uninfected, 85 (12.1%) had light, 24 (3.4%) moderate and 23
(3.3%) heavy infection. Among the praziquantel group (n= 640),
519 (81.1%) were uninfected, 80 (12.5%) had light, 23 (3.6%)
moderate and 18 (2.8%) heavy infection. Thus of the 1343
children, 253 (132 placebo, 121 praziquantel) were of women that
had S. mansoni during pregnancy and 1090 (571 placebo, 519
praziquantel) were of uninfected women. Women that had S.
mansoni at enrolment were less likely to live in Entebbe town and
more likely to have regular contact with lake water (Table 1).
S. mansoni infection among children of the cohort at 5
years old
Overall, 32 of the 1343 children (2.4%) had S. mansoni infection
at age five years based on a single stool sample. Of these 11
children (3 placebo group and 8 praziquantel group) were of
women that had S mansoni infection during pregnancy while 21 (10
placebo group, 11 praziquantel group) were of uninfected women.
Despite the few children infected, some had a high infection
intensity with a geometric mean infection intensity of 106 eggs per
gram (epg) of stool (minimum 12 epg, maximum 3384 epg). Fifteen
(45.9%) had light (,100 epg), twelve (37.5%) had moderate (100–
399 epg) and five (15.6%) had heavy (.400 epg) infections [21].
Table 1. Baseline characteristics at enrolment (during pregnancy) for the mothers of the children examined at age 5 years.
Placebo (n =703) Praziquantel (n = 640)
Mother had S. mansoni Mother uninfected Mother had S. mansoni Mother uninfected
(n =132 (18.8%)) (n =571) (n =121 (18.9%)) (n =519)
Maternal helminth infections
Hookworm 52 (39.4%) 230 (40.3%) 48 (39.7%) 231 (44.5%)
Mansonella perstans 20 (15.2%) 114 (20.0%) 12 (10.0%) 125 (24.1%)
Trichuris 21 (15.9%) 40 (7.0%) 15 (12.4%) 42 (8.1%)
Ascaris 2 (1.5%) 14 (1.5%) 8 (6.6%) 8 (1.5%)
Any worm 132 (100%) 314 (55.0%) 121 (100%) 308 (59.0%)
Mother education
None 8 (6.1%) 13 (2.3%) 2 (1.7%) 16 (3.1%)
Primary 66 (50.0%) 281 (49.3%) 67 (55.4%) 255 (49.2%)
Secondary 50 (37.9%) 226 (39.7%) 46(38.0%) 192 (37.1%)
Tertiary 8 (6.1%) 50 (8.8%) 6(5.0%) 55 (10.6%)
House hold socioeconomic status
1(low) 5 (3.8%) 35 (6.1%) 7 (5.8%) 32 (6.2%)
2 11 (8.3%) 41 (7.2%) 10 (8.3%) 36 (6.9)
3 42 (31.8%) 153 (26.8%) 30 (24.8%) 160 (30.8%)
4 45 (34.1%) 167 (29.3%) 43 (35.5%) 143 (27.6%)
5 21 (15.9%) 129 (22.6%) 21 (17.4%) 104 (20.0%)
6(high) 5 (3.8%) 36 (6.3%) 7 (5.8%) 36 (6.9%)
Missing the information 3 (2.3%) 10 (1.8%) 3 (2.5%) 8 (1.5%)
Location
Entebbe town 38 (28.8%) 237 (41.5%) 34 (28.1%) 194 (37.4%)
Kigungu 22 (16.7%) 65 (11.4%) 21 (17.4%) 66 (12.7%)
Manyago 46(34.9%) 148 (25.9%) 42 (34.7%) 145 (27.9%)
Katabi road side 9 (6.8%) 71 (12.4%) 6 (5.0%) 70 (13.5%)
Katabi off road 16 (12.1%) 44 (7.7%) 17 (14.1%) 40 (7.7%)
Other 1 (0.8%%) 6 (1.1%) 1 (0.8%) 4 (0.8%)
Mother Lake water contact
Never 36 (27.3%) 211 (37.0%) 24 (19.8%) 199 (38.3%)
Rarely 38 (28.9%) 150 (26.3%) 39 (32.2%) 112 (21.6)
Weekly 9 (6.8%) 29 (5.1%) 13 (10.7%) 22 (4.2)
Daily 11 (8.3%) 33 (5.8%) 13 (10.7%) 31 (6.0%)
Missing the information 38(28.8%) 148 (25.9%) 32 (26.5%) 155 (29.9%)
doi:10.1371/journal.pntd.0002501.t001
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Among the children with S mansoni in the placebo group (n= 13), 5
had light, 6 moderate and 2 heavy infection while among those in
the praziquantel group (n = 19), 10 had light, 6 moderate and 3
heavy S. mansoni infection.
Soil transmitted helminth seen among the children at age 5
years were hookworm 6 (0.4%), Ascaris 13 (1.0%), and Trichuris 73
(5.5%) and were mainly among the children with no S. mansoni
infection. No children with S mansoni had hookworm or Ascaris and
four children had co-infection of S mansoni and Trichuris.
We explored the association of factors including maternal
helminth infections and treatment, location of residence, contact
with lake water, maternal education, and household socioeco-
nomic status (a score based on the house building materials,
number of rooms and items owned), with the presence of S. mansoni
infection in the children. As expected, contact with lake water and
location of residence were associated with the children having S.
mansoni infection (Table 2). Children whose mothers who resided
in Kigungu or Katabi village (lakeside locations) were more likely
to have S. mansoni infection than those from Entebbe town, which
is not directly on the lakeshore. It was also noted that the
proportion of children that reported having been ‘in contact with
lake water frequently’ was greater for Kigungu (38.5%) and Katabi
village (24.8%) than Entebbe town (14.5%), Katabi town (6.9%) or
Manyago (11.5%) (P,0.001). Although crude analysis suggested
that maternal S. mansoni infection was associated with S. mansoni
infection among the children at five years old, on adjusting for the
other factors (location of residence, contact with lake water,
maternal education, and household socioeconomic status) this
association was lost. Trial analysis showed that praziquantel
treatment of the women during pregnancy had a tendency to
increase the chances of their offspring being infected (Table 3),
although this was not statistically significant. The effect of
praziquantel treatment appeared somewhat stronger among
children of mothers with S. mansoni, although again it was not
significantly different to the effect of treatment among children of
uninfected mothers (interaction p= 0.249). Because the prevalence
Table 2. Factors associated with S. mansoni infection among children at age five years old.
Variable
S. mansoni
prevalence
among the
children at age
five years Crude OR (95%CI)
Multivariable adjusted OR*
(95% CI)
Likelihood ratio
p-value
Maternal S. mansoni infection
Un infected (n = 1090) 1.90% 1 1
Infected (n = 253) 4.40% 2.3 (1.1, 4.9) 1.1 (0.4, 3.3) 0.796
Location
Entebbe town (n = 503) 0.80% 1 1
Kigungu (n = 174) 6.30% 8.4(2.6, 26.8) 4.5 (0.8, 25.0)
Manyago (n = 381) 1.30% 1.7 (0.4, 6.2) 3.3 (0.5, 22.3)
Katabi town (n = 156) 0% - -
Katabi village (n = 117) 10.30% 14.3 (4.5, 45.1) 18.6 (3.3, 104.2) 0.002
Maternal contact with lake water
Never (n = 470) 0.60% 1 1
Rarely (n = 339) 2.10% 3.3 0.8, 12.8) 1.0 (0.2, 6.8)
Weekly (n = 73) 5.50% 9.0 (2.0, 41.2) 1.8 (0.2, 15.5)
Daily (n = 88) 13.60% 24.6 (6.8, 89.1) 3.7 (0.5, 27.1) 0.282
Maternal Socioeconomic status
V. Poor (n = 177) 4.50% 1 1
Poor (n = 385) 2.60% 0.6 (0.2, 1.5) 0.9 (0.2, 3.3)
Fair (n = 398) 2.00% 0.4 (0.2, 1.2) 0.8 (0.2, 2.9)
Better (n = 359) 1.40% 0.3 (0.1, 0.9) 0.3 (0.04, 1.9) 0.533
Maternal Education
None (n = 39) 2.60% 1 1
Primary (n = 669) 3.00% 1.2 (0.2, 9.0) 0.5 (0.1, 5.5)
Secondary (514) 1.80% 0.7 (0.1, 5.5) 0.2 (0.02, 2.8)
Tertiary (119) 1.70% 0.6 (0.1, 7.4) 0.3 (0.01, 12.4) 0.474
Child contact with lake water
Never (n = 486) 0.40% 1 1
Rare (n = 195) 4.60% 11.7 (2.5, 54.7) 7.1 (1.3, 40.7)
Weekly (n = 41) 9.80% 26.2 (4.6, 147.6) 7.9 (1.0, 63.5)
Daily (n = 46) 19.60% 58.9 (12.3, 282.4) 21.4 (3.0, 151.0) 0.006
*Multivariable analysis odds ratios adjusted for variables presented in the table as well as maternal hookworm and microfilaria infection.
doi:10.1371/journal.pntd.0002501.t002
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of S. mansoni infection was low at five years, we also explored for
effects of maternal praziquantel treatment during pregnancy on
prevalence of S. mansoni infection among the study cohort children
using a repeated measures analysis combining all data from annual
time points to date (comprising age one to six for the youngest, and
one to eight years for the oldest children, depending on the child’s
age at the time of the analysis). Again, no association was observed
OR 0.80 (95% CI 0.57, 1.13 p= 0.21).
Cytokine responses to SWA and SEA among the children
at age five years
Four hundred and thirty six children were examined for IFNc,
IL-5, IL-10 and IL-13 responses to SWA and SEA. Of these, 207
were the offspring of women who received praziquantel treatment
during pregnancy (praziquantel group) and 229 were of women
who did not receive the treatment (placebo group). Restricting our
initial analysis to the placebo group, we examined whether
cytokine responses to SWA or SEA among the children differed
between children of S. mansoni infected women and those of
uninfected women (Table S1 in Text S1). Maternal S. mansoni
infection did not show any significant associations with cytokine
responses among the children, with the exception of IL-10
responses to SWA; children of women that had S. mansoni during
pregnancy had lower IL-10 responses to SWA (geometric mean
(cytokine concentration +1) = 6.1 pg/mL) than children of unin-
fected women (geometric mean (cytokine concentra-
tion+1) = 3.5 pg/mL, geometric mean ratio 0.58, 95%CI 0.39,
0.90)). We examined for associations between cytokine responses
and maternal infection intensity during pregnancy and found no
significant correlation (data not shown).
When we examined for effects of praziquantel treatment of S.
mansoni during pregnancy on cytokine responses among the
children, significant effects were only seen for IL-10 responses to
SWA where the responses were higher among children of women
who received praziquantel treatment during pregnancy (geometric
mean (cytokine concentration +1) = 3.5 pg/mL) than those of
women who were not treated (geometric mean (cytokine
concentration +1) = 7.0 pg/mL, (geometric mean ratio 1.97,
95%CI 1.25, 3.23)). More information can be viewed in Table
S2 in Text S1. Of the children examined for cytokine responses,
20 children had S. mansoni infection at age five years. As expected,
cytokine responses were higher in children with S. mansoni than
those without (Figure 1) and the cytokine profile among the
children was a mixed type 1, type 2, and regulatory response.
Among the uninfected children, praziquantel treatment during
pregnancy did not influence cytokine responses to SWA or SEA
Table 3. Effect of praziquantel treatment during pregnancy on S. mansoni infection status in children at age five years.
Treatment during pregnancy Children with S. mansoni (%) OR (95% CI) p value
Overall*
Placebo (n = 703) 13 (1.9%) 1
Praziquantel (n = 640) 19 (3.0%) 1.6 (0.80, 3.32) p = 0.183
Mother had S mansoni
Placebo (n = 132) 3 (2.3%) 1
Praziquantel (n = 121) 8 (6.6%) 3.0 (0.79, 11.75) p = 0.106
Mother uninfected
Placebo (n = 561) 10 (1.8%) 1
Praziquantel (n = 519) 11 (2.1%) 1.2 (0.51, 2.88) p = 0.659
doi:10.1371/journal.pntd.0002501.t003
Figure 1. Cytokine responses to SWA (A) or SEA (B) among children at age five years. Comparisons are shown between uninfected
children (n = 390) and infected children (n = 20). Presented are Wilcoxon rank-sum test p-values.
doi:10.1371/journal.pntd.0002501.g001
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except for IL-10, for which the responses to SWA were still higher
among children of women who received praziquantel treatment
compared with those of untreated women (geometric means 6.1
and 4.4 pg/mL, respectively geometric mean ratio 1.38 (95% CI
1.01, 1.90); Figure 2). The low number of infected children limited
similar subgroup analysis among the infected children. Neverthe-
less, the responses among the few (4 placebo group, 16
praziquantel group) infected children at age five years presented
a different picture from the responses among the uninfected
children (Figure 3; compare A with B for SWA or C with D for
SEA). Praziquantel treatment of the women during pregnancy
showed a tendency to reduce IFNc, IL-5, and IL-13 responses to
SWA and SEA, but not IL-10 in infected children.
Levels of antibodies to SWA and SEA among children at
age five years
Levels of IgG1, IgG4 and IgE to SWA and SEA were measured
in 226 children at age five years. Of these, 142 (63 placebo and 79
praziquantel group) were the off-spring of women infected with S.
mansoni during pregnancy and 84 (54 placebo and 30 praziquantel
group) of uninfected women. Among the 226 children, SWA-
specific IgG1 antibodies were detectable in 79 (35.0%) children,
with SWA-specific IgG4 and IgE antibodies detected in 12 (5.3%)
children. SEA-specific IgG1, IgG4 and IgE antibodies were
detectable in 56 (24.8%), 52 (23.0%) and 33 (14.6%) children
respectively. Of the children examined for antibody responses, 28
had S. mansoni at age five years. As expected, antibody levels
showed associations with the children’s infection status. Of the 28
children that had S .mansoni infection, IgG1, IgG4 and IgE to SWA
were detectable in 21 (75%), 7 (25%) and 9 (32.1%) of the children
respectively, and IgG1, IgG4 and IgE to SEA were detectable in
21 (75%), 19 (67.9%) and 15 (53.6%) children, respectively. Levels
of IgG1, IgG4 and IgE to SWA or SEA were minimal among
uninfected children and were significantly lower than the levels
among the S. mansoni infected children (Figure 3, p,0.001 for the
respective comparisons). Maternal infection intensity was not
associated with antibody levels (data not shown) and there were no
significant effects of praziquantel treatment during pregnancy on
antibody levels among the offspring (Figure 4).
Expression of regulatory T cell (Treg) phenotype among
the children at age five years
Considering that S. mansoni infection has been associated with
developing a strong immune regulatory response early in the initial
Figure 2. Effect of praziquantel treatment during pregnancy on cytokine responses to SWA or SEA among the children infected or
not infected with S mansoni at age 5 years. Infected children, praziquantel group (PZQ) n = 14, placebo n= 6; uninfected children, PZQ n= 178,
placebo n= 206. Shown are levels of cytokine production in response to SWA (A & B) or SEA (C &D).
doi:10.1371/journal.pntd.0002501.g002
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encounter between the host and parasite [28], we explored
whether maternal infection or treatment during pregnancy may
influence long-term Treg expression in the offspring. Two
hundred and nine children at age five years were examined for
CD4+ T cell expression of FoxP3. Of these, 128 were the offspring
of women infected with S. mansoni during pregnancy and 81 of
uninfected women. Of the infected women, 68 received prazi-
quantel treatment and 60 did not. We examined for effects of S.
mansoni infection and praziquantel treatment during pregnancy on
FoxP3 expression among offspring of women that were not treated
during pregnancy. Maternal S. mansoni infection was not associated
with FoxP3 expression in the children at age five years (data not
shown) and praziquantel treatment during pregnancy did not
influence expression of FoxP3 among the children (Table 4). Of
the 209 children examined for FoxP3 expression, only 17 were
infected with S. mansoni at age five years. FoxP3 expression was
higher among the S. mansoni infected children than the uninfected
children (Figure S3). We examined for associations between FoxP3
Treg expression and cytokine responses and found no significant
associations (data not shown). This was done on pooled data as
well as separately according to the children S. mansoni infection
status.
Discussion
This study explored the effects of S. mansoni infection and of
praziquantel treatment during pregnancy on S. mansoni infection
and immune responsiveness among the offspring at the age of five
years. This is an age by which the children are expected to have
had their first exposure to infection with S. mansoni through playing
in lake water. We found no conclusive evidence of an effect of
maternal schistosomiasis, or of its treatment during pregnancy, on
susceptibility to S. mansoni infection in the children, or on their
anti-schistosome antibody levels. Similarly, no effect on cytokine
responses to schistosome antigens was observed in the children
apart from IL-10 responses to SWA, for which children of infected
Figure 3. Antibody levels to SWA or SEA among children at age five years. Shown are plasma levels of antibodies to SWA (A) or SEA (B)
among uninfected children (n = 390) and infected children (n = 20) at age five years. ** Wilcoxon rank-sum test p,0.001.
doi:10.1371/journal.pntd.0002501.g003
Figure 4. Effect of praziquantel treatment of women during pregnancy on levels of antibodies to SWA or SEA among their
offspring having S. mansoni at age 5 years. Shown are plasma levels of antibodies to SWA (A) or SEA (B) among children that had S mansoni
infection at age five years.
doi:10.1371/journal.pntd.0002501.g004
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mothers tended to show lower responses than children of
uninfected mothers, and children of praziquantel-treated mothers
showed higher responses than children of placebo-treated mothers.
In this study the prevalence of S. mansoni among the five years
old children was 2.4%. This was based on a single stool sample,
implying that a number of infected children could have been
misclassified due to the low sensitivity of a single stool sample Kato
Katz test [29], and that these numbers may represent an under
estimate of the actual prevalence [29,30]. The observed preva-
lence was less than what has been reported from epidemiological
surveys involving preschool children in other areas on the shores of
Lake Victoria [31,32,33]. These studies were different from our
study in that they applied consecutive multiple stool sample Kato
Katz analysis. Further, the Entebbe area, where our study was
carried out, is relatively urbanised and developing rapidly, and has
wide availability of treated piped water. It is thus expected to have
relatively low S. mansoni transmission. However, we noted that
even under such low transmission conditions, infected young
children might have quite high infection intensities. Children who
were resident in the peri-urban areas of Kigungu and off road
areas of Katabi were more likely to be infected with S. mansoni than
children in the urban centres of Entebbe town and Katabi, and
this is a direct connection to the frequency of contact with lake
water. This underscores the concern that in situations where
younger children are exposed to potential sources of infection, they
will acquire the infection at an early age. This has implications on
schistosomiasis control programs that have tended to neglect
preschool children [34].
This study found no evidence that maternal S. mansoni infection
per se or maternal praziquantel treatment may predispose children
to infection with S. mansoni. Others have reported that children
born to women with filariasis [35], and those affected by placental
malaria [36], are likely to be infected earlier with the respective
parasites, an effect that has been attributed to the induction of
tolerance in the offspring [6]. Considering that our study included
very few children showing infection at age five years, there is a
further need to explore this effect in an area of high S. mansoni
transmission. However, repeated measures analysis showed
consistent observation among the cohort children at ages one to
eight years gave further evidence that maternal praziquantel of S.
mansoni during pregnancy may not influence prevalence of
infection among offspring.
Cytokine responses among the children had a mixed type 1/
type 2/regulatory profile. The same cytokine profile was found
among mothers of the children in this study cohort [27], and
immunoepidemiological studies have also shown a mixed
responses with strong regulatory cytokine phenotype [37,38]. It
was also noted that expression of FoxP3 was prominent among the
S. mansoni infected children. Our findings show that, in S. mansoni
endemic areas, the profile of T-cell responses typical to those in S.
mansoni chronically infected adults may be established in early
childhood. For the observational analyses, where we compare
infected and uninfected children, we observed quite marked
differences in the immune responses in the children. Considering
that we applied a single stool sample Kato Katz for diagnosis,
misclassification of infected children as uninfected might have
weakened the differences observed. Therefore these results are
probably a conservative estimate of the effects of infection on
immune responses in the children.
Praziquantel treatment during pregnancy did not influence
most of the assayed cytokine responses to SWA or SEA. This
finding is consistent with our earlier report in which we did not
find significant effects of praziquantel treatment during pregnancy
on cytokine responses to schistosome antigens among the
offspring, in either cord blood or at age one year [3]. Of some
interest, however, was the IL-10 response to SWA. This was an
exception in that it was low in the offspring of mothers with S.
mansoni infection and was increased by praziquantel treatment
during pregnancy. IL-10 is a regulatory cytokine, capable of
switching off both type 1 and type 2 immune responses, and could
possibly explain why we saw consistently low IFNc, IL-5, and IL-
13 responses among infected offspring of women who received
praziquantel treatment during pregnancy compared to offspring of
those who did not (Figure 3 B&C). This could have implications on
S. mansoni associated morbidity among the offspring. For example,
low regulatory and type 2 responses to schistosome antigens have
been associated with hepatosplenomegaly in childhood schistoso-
miasis [15]. In addition, low levels of regulatory cytokines and
Table 4. Effect of praziquantel treatment during pregnancy on regulatory T cells expression among offspring at age five years.
%CD4 expressing FoxP3
Level of FoxP3 Expression (Geometric mean
fluorescence intensity (GMFI))
Geometric Means Geometric mean ratio (95% CI) Geometric Mean
Geometric mean ratios
(95%CI)
Overall
Placebo (n = 112) 3.8 534.5
Praziquantel (n = 97) 3.6 0.61 (0.21, 1.76) 630.6 1.18 (0.93, 1.47)
Mother had S. mansoni
Placebo (n = 60) 3.7 591.4
Praziquantel (n = 68) 3.2 0.33 (0.09, 1.38) 586.2 0.99 (0.73, 1.34)
Uninfected children
Placebo (n = 103) 3.7 521.6
Praziquantel (n = 85) 3.7 0.97 (0.32, 3.13) 586.7 1.12 (0.87, 1.45)
Children with S. mansoni
Placebo (n = 7) 4.7 755.2
Praziquantel (n = 10) 2.7 0.01 (0, 0.33) 897.5 1.19 (0.41, 2.85)
doi:10.1371/journal.pntd.0002501.t004
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correspondingly higher levels of type 2 cytokines have been
associated with a high risk of peri-portal fibrosis in chronic S.
mansoni [18,39] and S. japonicum [40]. In S. japonicum infection pro-
inflammatory cytokines including IL-1, IL-6 and TNF have been
associated with morbidity outcomes [41]. On the other hand,
immunosuppressive responses are presumed to allow establish-
ment and prolong survival of the worms in the host, preventing
elimination of the parasite while at the same time minimizing
tissue damage [42,43,44]. In our study the observations on IL-10,
a regulatory cytokine, were not reflective of the regulatory T-cell
data in terms of FoxP3 expression. However, IL-10 responses were
measured after in vitro antigen stimulation of whole blood cultures,
and it is likely that sources other than T cells also contributed to
IL10 production. The observed effect on IL-10 response may have
implications on schistosomiasis-associated morbidity, and this need
further immunological and morbidity studies
In conclusion, and considering that the low S. mansoni
prevalence in this study was a major limitation, our findings show
no evidence that maternal S. mansoni infection or its treatment
during pregnancy has an influence on the prevalence of S. mansoni
infection among the offspring at age five years. However, our
findings do suggest that maternal S. mansoni and its treatment
during pregnancy may affect some cytokine responses among S.
mansoni infected offspring at age five years. The magnitude of such
an effect and possible implications in childhood schistosomiasis
need to be elucidated further by conducting a larger study
involving greater numbers of infected children.
Supporting Information
Figure S1 Cytokine levels in supernatants of unstimulated
cultures.
(PPTX)
Figure S2 Example of the gating strategy applied for regulatory
T cell. The gate for A) Lymphocytes, B) selection to eliminate
duplicates, C) CD4+ cells gate selection, D) CD4+CD25 high
CD127 low selection and E) FoxP3 expression in the CD25hiC-
D127lo gated cell population.
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Figure S3 Expression of FoxP3 among children infected or
uninfected with S. mansoni at age 5 years. On the Y-axis is the log10
(geometric mean fluorescent intensity (GMFI)+1).
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Text S1 Shown in table S1 is the association of maternal S.
mansoni infection during pregnancy with cytokine responses to
SWA or SEA among children (n= 229) at age five years, and in
table S2 is the effect of praziquantel treatment of S mansoni
during pregnancy on cytokine responses to SWA/SEA in offspring
at age five years.
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